Belpointe Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-611	Closed	-$917	–	2118
2023 Q1	$917	Hold	611	–	–	﹤0.01%	3489
2022 Q4	$715	Buy	+611	New	+$715	﹤0.01%	3494